Кости: болезни костей метаболические, литература
1.Blake GM, et al. Vertebral morphometry studies using dual-energy x-ray absorptiometry. Semin Nucl Med 27:276,1997.
2. Bone HG, Kleerekoper M. Clinical review 39: Paget's disease of bone. J Clin Endocrinol Metab 75:1179, 1992.
3.Chines A, Pacifici R. Antiacid and sucralfate-induced hypophosphatemic osteomalacia: A case report and review of the literature. Calcif Tissue Int 47:291, 1990.
4. Christiansen С, Riis BJ. 17 beta-estradiol and continuous norethisterone:A unique treatment for established osteoporosis in elderly women. J Clin Endocrinol Metab 71:836, 1990.
5.Delmez JA, Slatopolsky E. Recent advances in the pathogenesis and therapy ofuremic secondary hyperparathyroidism. J Clin Endocrinol Metab 72;735, 1991.
6.Delvin ЕЕ, et al. Vitamin D dependency: Replacement therapy with calcitriol. J Pediatr 99:26, 1981.
7.Gluer CC. Quantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus Group. J Bone Miner Res 12:1280, 1997.
8.Hahn TJ. Drug-induced disorders of vitamin D and mineral metabolism. Clin Endocrinol Metab 9:107, 1980.
9.Liberman UA, et al. Resistance to 1,25-dihydroxyvitamin D: Association with heterogenous defects in cultured skin fibroblasts. J Clin Invest 71:192, 1983.
10.Ljunghall S, et al. Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind study. Calcif Tissue Int 49:17, 1991.
11. Malluche H, Fuagere MC. Renal bone disease 1990: An unmet challenge for the nephrologist. Kidney Int 38:193, 1990.
12. Marcus R. Estrogens and progestins in the management of primary hyperparathyroidism. Endocrinol Metab Clin North Am 18:715, 1989.
13. Nuovo MA, et al. Tumor-induced osteomalacia and rickets Am J Surg Path 13:588, 1989.
14. Reid IR, et al. X-linked hypophosphatemia: A clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 68:336, 1989.
15. Riggs BL, Melton LJ III. Involutional osteoporosis. New Engi J Med 314:1676, 1986.
16. Siris E, et al. Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961,1996.
17. Stewart AF, Brodus AE. Parathyroid hormone-related proteins: Coming of age in the 1990s. J Clin Endocrinol Metab 71:1410,1990.
18. Storm Т, et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. New Engi J Med 322:1265, 1990.
19. Terry LP, et al. Long-term thyroxine therapy is associated with decreased bone density in premenopausal women. JAMA 259:3137, 1988.
20. Wahner HW. Measurements of bone mass and bone density. Endocrinol Metab Clin North Am 18:995, 1989.
21. Walton RJ, Bijvoet OLM. Nomogram for derivation of renal threshold phosphate concentration. Lancet 2:309, 1975.
